Chromatin-modifying proteins in cancer

被引：22
作者：
Fog, Cathrine K. [1 ]
Jensen, Klaus T. [1 ]
Lund, Anders H. [1 ]
机构：
[1] Univ Copenhagen, Ctr Epigenet, Biotech Res & Innovat Ctr, DK-1168 Copenhagen, Denmark
来源：
APMIS | 2007年 / 115卷 / 10期
关键词：
chromatin; epigenetics; cancer; DNA methylation; histone code;
D O I：
10.1111/j.1600-0463.2007.apm_776.xml.x
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Chromatin-modifying proteins mold the genome into areas that are accessible for transcriptional activity and areas that are transcriptionally silent. This epigenetic gene regulation allows for different transcriptional programs to be conducted in different cell types at different timepoints-despite the fact that all cells in the organism contain the same genetic information. A large amount of data gathered over the last decades has demonstrated that deregulation of chromatin-modifying proteins is etiologically involved in the development and progression of cancer. Here we discuss how epigenetic alterations influence cancer development and review known cancer-associated alterations in chromatin-modifying proteins.
引用
收藏
页码：1060 / 1089
页数：30
相关论文
共 340 条
  • [1] Alessandrino EP, 2001, HAEMATOLOGICA, V86, P1124
  • [2] Perturbation of B and T cell development and predisposition to lymphomagenesis in E mu Bmi1 transgenic mice require the Bmi1 RING finger
    Alkema, MJ
    Jacobs, H
    vanLohuizen, M
    Berns, A
    [J]. ONCOGENE, 1997, 15 (08) : 899 - 910
  • [3] PTEN promoter methylation in sporadic thyroid carcinomas
    Alvarez-Nuñez, F
    Bussaglia, E
    Mauricio, D
    Ybarra, J
    Vilar, M
    Lerma, E
    de Leiva, A
    Matias-Guju, X
    [J]. THYROID, 2006, 16 (01) : 17 - 23
  • [4] Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
    Amir, RE
    Van den Veyver, IB
    Wan, M
    Tran, CQ
    Francke, U
    Zoghbi, HY
    [J]. NATURE GENETICS, 1999, 23 (02) : 185 - 188
  • [5] NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines
    Angrand, PO
    Apiou, F
    Stewart, AF
    Dutrillaux, B
    Losson, R
    Chambon, P
    [J]. GENOMICS, 2001, 74 (01) : 79 - 88
  • [6] NUMBER OF CPG ISLANDS AND GENES IN HUMAN AND MOUSE
    ANTEQUERA, F
    BIRD, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) : 11995 - 11999
  • [7] Increased expression of EZH2, a polycomb group protein, in bladder carcinoma
    Arisan, S
    Buyuktuncer, ED
    Palavan-Unsal, N
    Çaskurlu, T
    Çakir, OO
    Ergenekon, E
    [J]. UROLOGIA INTERNATIONALIS, 2005, 75 (03) : 252 - 257
  • [8] Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins
    Ayton, PM
    Cleary, ML
    [J]. ONCOGENE, 2001, 20 (40) : 5695 - 5707
  • [9] EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
    Bachmann, IM
    Halvorsen, OJ
    Collett, K
    Stefansson, IM
    Straume, O
    Haukaas, SA
    Salvesen, HB
    Otte, AP
    Akslen, LA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (02) : 268 - 273
  • [10] MBD1, MBD2 and CGBP genes at chromosome 18q21 are infrequently mutated in human colon and lung cancers
    Bader, S
    Walker, M
    McQueen, HA
    Sellar, R
    Oei, E
    Wopereis, S
    Zhu, YH
    Peter, A
    Bird, AP
    Harrison, DJ
    [J]. ONCOGENE, 2003, 22 (22) : 3506 - 3510
12345678910